Edward P Amento Selected Research

Edward P Amento Research Topics

4	Fibrosis (Cirrhosis) 10/2005 - 01/2003
3	Inflammation (Inflammations) 07/2020 - 01/2014
2	Wounds and Injuries (Trauma) 07/2020 - 01/2020
2	Sepsis (Septicemia) 07/2020 - 01/2020
2	Burns 07/2020 - 01/2020
2	Atherosclerosis 11/2017 - 10/2016
1	Pathologic Neovascularization 07/2020
1	Weight Gain 07/2020
1	Neuroinflammatory Diseases 01/2020
1	Dyslipidemias (Dyslipidemia) 11/2017
1	Alzheimer Disease (Alzheimer's Disease) 02/2015
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 10/2005
1	Cicatrix (Scar) 10/2005
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2003

4	RelaxinIBA 10/2005 - 01/2003
4	CollagenIBA 10/2005 - 01/2003
2	CreatinineIBA 07/2020 - 06/2004
2	Peptides (Polypeptides)IBA 07/2020 - 01/2020
1	peptide AIBA 07/2020
1	Valproic Acid (Depakote)FDA LinkGeneric 07/2020
1	InflammasomesIBA 01/2020
1	IronIBA 01/2020
1	Inosine FDA Link 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	oxidized low density lipoproteinIBA 11/2017
1	HDL LipoproteinsIBA 11/2017
1	HDL CholesterolIBA 11/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 11/2017
1	LipidsIBA 11/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2016
1	Biomarkers (Surrogate Marker)IBA 02/2015
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 01/2014
1	Collagen Type I (Type I Collagen)IBA 06/2004
1	Proteins (Proteins, Gene)FDA Link 06/2004
1	Peptide Hormones (Polypeptide Hormones)IBA 06/2004

1	Glycemic Control 07/2020
1	Therapeutics 11/2017